Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1042/CS20200163 http://scihub22266oqcxt.onion/10.1042/CS20200163 32167153!ä!32167153 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Sci+(Lond) 2020 ; 134 (5): 543-545 Nephropedia Template TP {{tp|p=32167153|t=2020. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?|pdf=|usr=}}{{32167153}} gab.com Text Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy JO: Clin Sci (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=32167153 #FOAvip A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019, has spread to other regions of China and to 25 other countries as of January, 2020. It has been known since the 2003 SARS epidemic that the receptor critical for SARS-CoV entry into host cells is the angiotensin-converting enzyme 2 (ACE2). The S1 domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor ACE2 on the host cells. We thought that it is timely to explain the connection between the SARS-CoV, SARS-CoV-2, ACE2 and the rationale for soluble ACE2 as a potential therapy. Twit Text FOAVip Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy ????Clin Sci (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=32167153 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32167153 #FOAvip English Wikipedia <ref>{{Cite pmid|32167153}}</ref> Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? #MMPMID32167153 Batlle D; Wysocki J; Satchell K Clin Sci (Lond) 2020[Mar]; 134 (5): 543-545 PMID32167153show ga A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019, has spread to other regions of China and to 25 other countries as of January, 2020. It has been known since the 2003 SARS epidemic that the receptor critical for SARS-CoV entry into host cells is the angiotensin-converting enzyme 2 (ACE2). The S1 domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor ACE2 on the host cells. We thought that it is timely to explain the connection between the SARS-CoV, SARS-CoV-2, ACE2 and the rationale for soluble ACE2 as a potential therapy. |*Peptidyl-Dipeptidase A/physiology[MESH] |*Virus Attachment[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Animals[MESH] |Betacoronavirus/*pathogenicity[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Cell Line[MESH] |Coronavirus Infections/*drug therapy[MESH] |Haplorhini[MESH] |Humans[MESH] |Pneumonia, Viral/*drug therapy[MESH] |Recombinant Proteins/therapeutic use[MESH] |SARS-CoV-2[MESH] |Severe acute respiratory syndrome-related coronavirus/*pathogenicity[MESH] |Solubility[MESH]Soluble angiotensin-converting enzyme 2: a potential approach for coro(epmc).pdf DeepDyve Pubget Overpricing